July 11 - WhoWhatWhy July 11 - WhoWhatWhy

John F. Kennedy space program
On July 11th 1962, NASA announced selection of the Apollo program moon landing technique. It follows President John F. Kennedy's historical message to Congress, "I believe this Nation should commit itself to achieving the goal, before this decade is out, of landing a man on the Moon and returning him safely to the Earth." About this photo: President John F. Kennedy, Vice President Lyndon B. Johnson, Jacqueline Kennedy and others watching the flight of Astronaut Alan Shepard. The president proposed the Moon landing only 20 days later.  Photo credit: NARA / Wikimedia

July 11

Japan Votes to Amend ‘Pacifist’ Constitution, The Dark Side of Pharma Marketing, Clinton Appointees Promote TPP to DNC, and More Picks

PICKS are stories from many sources, selected by our editors or recommended by our readers because they are important, surprising, troubling, enlightening, inspiring, or amusing. They appear on our site and in our daily newsletter. Please send suggested articles, videos, podcasts, etc. to picks@whowhatwhy.org.

Barrett Brown’s Prison Musings (Russ)

Barrett Brown, the “hacktivist journalist” whose struggles with the security state WhoWhatWhy covered, now provides a journal of life on the inside and thoughts about the outside.

Japan Votes to Amend ‘Pacifist’ Constitution (Dan)

Japan’s PM Shinzo Abe has been focused on amending Japan’s ‘non-militaristic’ constitution to allow for more intervention. Now he may have the votes.

Tony Blair Could Face Contempt of Parliament Motion Over Iraq War (Reader Pat)

MP’s from multiple parties indicate support for sanctioning Blair over Iraq War lies.

Clinton Democrats Still Undecided on TPP (Dan)

Despite both Sanders and Clinton withdrawing support for the TPP, Clinton appointees to the Democratic National Committee refuse to remove the trade deal from their platform.

Selling Side Effects: The Darker Side of Pharma Marketing (Trevin)

Companies spend billions convincing people they are sick and need drugs. Billions more go toward marketing drugs or devices to doctors — even those not approved by the FDA — and in payouts as a result of settlements for marketing fraud.

Author

Comments are closed.